Live Breaking News & Updates on உயிர் மருத்துவ கார்ப்
Stay updated with breaking news from உயிர் மருத்துவ கார்ப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xontogeny backs 3 Philadelphia-area life sciences startups - Philadelphia Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
IRW-News: Entheon Biomedical Corp.: Entheon Biomedical erlangt Notierung am OTCQB Venture Market boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
CanaQuest Medical Corp.: CanaQuest Files International Mentanine Patent, a Scientific CBD Formulation for Mental Health ) , an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine®, which has demonstrated at least 10-times (10X) the efficacy compared to Pharma Grade CBD. Mentanine® - an International CBD Excellence Award 2020 formulation was scientifically developed through preclinical trials at Western University. Results of its potential effect on anxiety, depression, PTSD, and schizophrenia have been statistically significant. Our evidence also found that this formulation targeted a specific nuclear cellular receptor involved in anti-inflammatory mechanisms indicating that this formula may also treat inflammatory disorders. ....
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
(0) TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the Company or CanaQuest ) , an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Mr. Rinderman will focus on managing a proactive investor relations and corporate communications program, further expanding investor community and media awareness about the company s material corporate developments and future prospects. We are delighted that a seasoned communications professional with decades of financial experience has agreed to join our team at this important time in our corporate evolution, stated CanaQuest President Paul Ramsay. We believe adding a veteran like Rob to help us present our story to a wider and receptive audience is a key asset for us moving forward. ....